The ultimate goal of the Clinical Services component of the St. Luke's- Roosevelt Hospital Sickle Cell Center is the establishment of uniformly excellent care of all patients with sickle cell disease, of all ages, provided through a well-organized clinical base. The care must extend through the spectrum of medical services from primary and preventive through crisis and tertiary, as well as beyond the purely medical into those ancillary activities - education, employment, finances, etc. - essential for the quality of life. If maximum effort is made to address the multiplicity of patient needs, he or she is more likely to remain under care in the program. The achievement of these goals requires a well trained, experienced committed and empathic staff, working together as a cohesive unit. The immediate goals of the subprojects of the center are: 1) To reduce the negative impact of recurrent pain in sickle cell disease through patient education and advocacy, by sickle cell staff augmented by volunteers, as well as by the extended use of patient controlled analgesia in the younger child, via nurse and parent, and to sites other than the inpatient ward, e.g., the emergency room. 2) To study age-related pitted red blood cells, and spleen function via spleen scans and other tests in patients with CC disease, compared to SC and SS patients since preliminary investigation has indicated that these patients have high pitted red blood cell counts, probably unrelated to spleen dysfunction. This project has clinical relevance for CC patients, and by extension to SC patients. 3) To explore certain aspects of immune function in sickle cell and CC patients, namely circulating immune complexes, immune complexes on the surface of red blood cells, classical and alternate complement pathways, and complement C3b receptors function activity. The demonstration of the cause of immune problems in sickle cell disease patients can potentially lead to prevention or therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL028381-15
Application #
6241729
Study Section
Project Start
1997-04-01
Project End
1998-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
15
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Prohovnik, Isak; Hurlet-Jensen, Anne; Adams, Robert et al. (2009) Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. J Cereb Blood Flow Metab 29:803-10
Manwani, Deepa; Galdass, Mariann; Bieker, James J (2007) Altered regulation of beta-like globin genes by a redesigned erythroid transcription factor. Exp Hematol 35:39-47
Weinberg, Rona S; Ji, Xinjun; Sutton, Millicent et al. (2005) Butyrate increases the efficiency of translation of gamma-globin mRNA. Blood 105:1807-9
Rubin, Camelia Iancu; French, Deborah L; Atweh, George F (2003) Stathmin expression and megakaryocyte differentiation: a potential role in polyploidy. Exp Hematol 31:389-97
Day, Nancy S; Tadin, Marija; Christiano, Angela M et al. (2002) Rapid prenatal diagnosis of sickle cell diseases using oligonucleotide ligation assay coupled with laser-induced capillary fluorescence detection. Prenat Diagn 22:686-91
Turhan, Aslihan; Weiss, Linnea A; Mohandas, Narla et al. (2002) Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A 99:3047-51
Iancu, C; Mistry, S J; Arkin, S et al. (2001) Effects of stathmin inhibition on the mitotic spindle. J Cell Sci 114:909-16
Frenette, P S; Weiss, L (2000) Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms. Blood 96:2460-8
Pearson, M J; Lipowsky, H H (2000) Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery. Am J Physiol Heart Circ Physiol 279:H1460-71
O'Neill, D W; Schoetz, S S; Lopez, R A et al. (2000) An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol 20:7572-82

Showing the most recent 10 out of 114 publications